Treatment of primary FSGS in adults

Journal of the American Society of Nephrology

Volumn 23, Issue 11, 2012, Pages 1769-1776

  Korbet, Stephen M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ 4; ANABOLIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CHLORAMBUCIL; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; DEXAMETHASONE; DIAMORPHINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALACTOSE; IMMUNOSUPPRESSIVE AGENT; LITHIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PAMIDRONIC ACID; PLACEBO; PODOCIN; PREDNISONE; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ADSORPTION; AFRICAN AMERICAN; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EDEMA; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; HISTOLOGY; HUMAN; HYPOALBUMINEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LOW DRUG DOSE; NEPHROTIC SYNDROME; NEPHROTOXICITY; PATHOGENESIS; PLASMAPHERESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REMISSION; SHORT SURVEY; TREATMENT RESPONSE;

EID: 84868624922     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012040389     Document Type: Short Survey

References (79)

1. Haas M, Spargo BH, Coventry S: Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study. Am J Kidney Dis 26: 740-750, 1995
2. Braden GL, Mulhern JG, O' Shea MH, Nash SV, Ucci AA Jr, Germain MJ: Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35: 878-883, 2000 (Pubitemid 30238200)
3. Swaminathan S, Leung N, Lager DJ, Melton LJ 3rd, Bergstralh EJ, Rohlinger A, Fervenza FC: Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol 1: 483-487, 2006
4. Haas M, Meehan SM, Karrison TG, Spargo BH: Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 30: 621-631, 1997 (Pubitemid 27465355)
5. Korbet SM, Genchi RM, Borok RZ, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 27: 647-651, 1996 (Pubitemid 26135836)
6. Pontier PJ, Patel TG: Racial differences in the prevalence and presentation of glomerular disease in adults. Clin Nephrol 42: 79-84, 1994 (Pubitemid 24247186)
7. Kitiyakara C, Eggers P, Kopp JB: Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 44: 815-825, 2004 (Pubitemid 39445913)
8. Rennke HG, Klein PS: Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 13: 443-456, 1989 (Pubitemid 19160779)
9. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334: 878-883, 1996 (Pubitemid 26107345)
10. McCarthy ET, Sharma M, Savin VJ: Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5: 2115-2121, 2010
11. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J: Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17: 952-960, 2011
12. Pollak MR: Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol 13: 3016-3023, 2002
13. Pollak MR: The genetic basis of FSGS and steroid-resistant nephrosis. Semin Nephrol 23: 141-146, 2003
14. Tryggvason K, Patrakka J, Wartiovaara J: Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354: 1387-1401, 2006
15. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F; Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004 (Pubitemid 38294803)
16. He N, Zahirieh A, Mei Y, Lee B, Senthilnathan S, Wong B, Mucha B, Hildebrandt F, Cole DE, Cattran D, Pei Y: Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2: 31-37, 2007
17. McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki MH, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA: NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol 18: 2987-2995, 2007 (Pubitemid 350058406)
18. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA: MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40: 1175- 1184, 2008
19. Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA: APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 2129-2137, 2011
20. Kopp JB, Winkler CA, Nelson GW: MYH9 genetic variants associated with glomerular disease: What is the role for genetic testing? Semin Nephrol 30: 409-417, 2010
21. Korbet SM: Treatment of primary focal segmental glomerulosclerosis. Kidney Int 62: 2301-2310, 2002
22. Korbet SM: Primary Focal Segmental Glomerulosclerosis. In: Therapy in Nephrology and Hypertension: A Companion to Brenner and Rector's The Kidney, edited by Brady RJ, Wilcox CS, 2nd Ed., Philadelphia, W.B. Saunders, 2003, pp 223-236
23. Kambham N, Markowitz GS, Valeri AM, Lin J, D 'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001 (Pubitemid 32281241)
24. Praga M, Morales E, Herrero JC, Pérez Campos A, Domínguez-Gil B, Alegre R, Vara J, Martínez MA: Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyper filtration. Am J Kidney Dis 33: 52-58, 1999 (Pubitemid 29031208)
25. Praga M, Hernández E, Morales E, Campos AP, Valero MA, Martínez MA, León M: Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 16: 1790-1798, 2001 (Pubitemid 32821410)
26. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry Group: Focal and segmental glomerulosclerosis: Definition and relevance of a partial remission. J Am Soc Nephrol 16: 1061-1068, 2005 (Pubitemid 41710316)
27. Beaufils H, Alphonse JC, Guedon J, Legrain M: Focal glomerulosclerosis: Natural history and treatment. A report of 70 cases. Nephron 21: 75-85, 1978 (Pubitemid 8351647)
28. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG: The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10: 213-218, 1978 (Pubitemid 9092035)
29. Korbet SM: Management of idiopathic nephrosis in adults, including steroid-resistant nephrosis. Curr Opin Nephrol Hypertens 4: 169-176, 1995
30. Velosa JA, Holley KE, Torres VE, Offord KP: Signi ficance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis. Mayo Clin Proc 58: 568-577, 1983 (Pubitemid 13004481)
31. Schwartz MM, Evans J, Bain R, Korbet SM: Focal segmental glomerulosclerosis: Prognostic implications of the cellular lesion. J Am Soc Nephrol 10: 1900-1907, 1999 (Pubitemid 29402510)
32. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ: Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15: 2169-2177, 2004 (Pubitemid 39031355)
33. Stirling CM, Mathieson P, Boulton-Jones JM, Feehally J, Jayne D, Murray HM, Adu D: Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM 98: 443-449, 2005 (Pubitemid 40796816)
34. Korbet SM: Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin Nephrol 23: 219-228, 2003
35. Korbet SM, Schwartz MM, Lewis EJ: Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 23: 773-783, 1994 (Pubitemid 24173558)
36. Cattran DC, Rao P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32: 72-79, 1998
37. Habib R: Editorial: Focal glomerular sclerosis. Kidney Int 4: 355-361, 1973
38. Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, Passerini P, Farina M, Grassi C, Baroli A: Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis 34: 618-625, 1999 (Pubitemid 29473046)
39. Agarwal SK, Dash SC, Tiwari SC, Bhuyan UN: Idiopathic adult focal segmental glomerulosclerosis: A clinicopathological study and response to steroid. Nephron 63: 168-171, 1993 (Pubitemid 23045240)
40. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment. Am J Kidney Dis 25: 534-542, 1995
41. Meyrier A, Noël LH, Auriche P, Callard P; Collaborative Group of the Société de Néphrologie: Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 45: 1446-1456, 1994
42. Banfi G, Moriggi M, Sabadini E, Fellin G, D 'Amico G, Ponticelli C: The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36: 53-59, 1991
43. Bolton WK, Atuk NO, Sturgill BC, Westervelt FB Jr: Therapy of the idiopathic nephrotic syndrome with alternate day steroids. Am J Med 62: 60-70, 1977 (Pubitemid 8025539)
44. Nagai R, Cattran DC, Pei Y: Steroid therapy and prognosis of focal segmental glomerulosclerosis in the elderly. Clin Nephrol 42: 18-21, 1994 (Pubitemid 24215995)
45. Senthil Nayagam L, Ganguli A, Rathi M, Kohli HS, Gupta KL, Joshi K, Sakhuja V, Jha V: Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: A pilot study. Nephrol Dial Transplant 23: 1926-1930, 2008 (Pubitemid 351768140)
46. Trachtman H, Greenbaum LA, McCarthy ET, Sharma M, Gauthier BG, Frank R, Warady B, Savin VJ: Glomerular permeability activity: Prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome. Am J Kidney Dis 44: 604-610, 2004 (Pubitemid 39237603)
47. Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G: Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: A pilot study. Am J Kidney Dis 41: 328-335, 2003 (Pubitemid 36152450)
48. Deegens JK, Wetzels JF: Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosis. Clin Nephrol 68: 201-208, 2007 (Pubitemid 47527439)
49. D'Agati V: Pathologic classi fication of focal segmental glomerulosclerosis. Semin Nephrol 23: 117-134, 2003
50. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 43: 368-382, 2004 (Pubitemid 38146337)
51. Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF: Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population- epidemiology and outcome. Nephrol Dial Transplant 23: 186-192, 2008 (Pubitemid 351767360)
52. Thomas DB, Franceschini N, Hogan SL, Ten Holder S, Jennette CE, Falk RJ, Jennette JC: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69: 920-926, 2006
53. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416-1424, 1994 (Pubitemid 24135029)
54. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50: 1734-1746, 1996 (Pubitemid 26364283)
55. Korbet SM, Schwartz MM: Primary focal segmental glomerulosclerosis: A treatable lesion with variable outcomes. Nephrology (Carlton) 6: 47-56, 2001 (Pubitemid 32398110)
56. Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD: Glomerular tip lesion: A distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney Int 65: 1690-1702, 2004 (Pubitemid 38591017)
57. Howie AJ, Pankhurst T, Sarioglu S, Turhan N, Adu D: Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int 67: 987-1001, 2005 (Pubitemid 41623322)
58. Haas M: The glomerular tip lesion: What does it really mean? Kidney Int 67: 1188-1189, 2005
59. Pei Y, Cattran D, Delmore T, Katz A, Lang A, Rance P: Evidence suggestingunder-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med 82: 938-944, 1987
60. Colattur SN, Korbet SM: Long-term outcome of adult onset idiopathic minimal change disease. Saudi J Kidney Dis Transpl 11: 334-344, 2000
61. Ponticelli C, Edefonti A, Ghio L, Rizzoni G, Rinaldi S, Gusmano R, Lama G, Zacchello G, Confalonieri R, Altieri P, Bettinellani A, Maschio G, Cinotti GA, Fuiano G, Schena FP, Castellani A, Della Casa-Alberighi O: Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial. Nephrol Dial Transplant 8: 1326-1332, 1993
62. Cattran D, Neogi T, Sharma R, McCarthy ET, Savin VJ: Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 14: 448-453, 2003 (Pubitemid 36150869)
63. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938, 2008
64. Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW: Direct effects of dexamethasone on human podocytes. Kidney Int 70: 1038-1045, 2006 (Pubitemid 44344073)
65. Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D: Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant 17: 2011-2013, 2002 (Pubitemid 35277104)
66. Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J: Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome. Pediatr Nephrol 20: 914-919, 2005 (Pubitemid 40909260)
67. Moudgil A, Bagga A, Jordan SC: Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: Current status and future directions. Pediatr Nephrol 20: 1376-1381, 2005 (Pubitemid 41403409)
68. Ponticelli C, Passerini P: Other immunosuppressive agents for focal segmental glomerulosclerosis. Semin Nephrol 23: 242-248, 2003 (Pubitemid 36397107)
69. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL; North America Nephrotic Syndrome Study Group: A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 56: 2220-2226, 1999 (Pubitemid 30004751)
70. Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Casa-Alberighi OD: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43: 1377-1384, 1993
71. Niaudet P; French Society of Pediatric Nephrology: Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J Pediatr 125: 981-986, 1994
72. Meyrier A, Condamin MC, Broneer D: Collaborative group of the société de néphrologie: Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis. Clin Nephrol 35[suppl 1]: 37-42, 1991
73. Meyrier A: Treatment of nephrotic syndrome with cyclosporin A. What remains in 1994? Nephrol Dial Transplant 9: 596-598, 1994
74. Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N: Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: Workshop recommendations. Kidney Int 72: 1429-1447, 2007 (Pubitemid 350197945)
75. Isnard Bagnis C, Tezenas du Montcel S, Beaufils H, Jouanneau C, Jaudon MC, Maksud P, Mallet A, LeHoang P, Deray G: Long-term renal effects of low-dose cyclosporine in uveitis-treated patients: follow-up study. J Am Soc Nephrol 13: 2962-2968, 2002 (Pubitemid 35386915)
76. Segarra A, Vila J, Pou L, Majó J, Arbós A, Quiles T, Piera LL: Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: A preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 17: 655-662, 2002 (Pubitemid 34308823)
77. Cattran DC, Wang MM, Appel G, Matalon A, Briggs W: Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol 62: 405-411, 2004 (Pubitemid 39654577)
78. Segarra A, Amoedo ML, Martinez Garcia JM, Pons S, Praga M, Garcia EI, Alonso JC, Gascó JM, Pou L, Piera L: Efficacy and safety of 'rescue therapy ' with mycophenolate mofetil in resistant primary glomerulonephritis - a multicenter study. Nephrol Dial Transplant 22: 1351-1360, 2007 (Pubitemid 47072223)
79. Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, Moxey-Mims MM, Hogg RJ, Watkins SL, Fine RN, Hogan SL, Middleton JP, Vehaskari VM, Flynn PA, Powell LM, Vento SM, McMahan JL, Siegel N, D 'Agati VD, Friedman AL: Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 80: 868-878, 2011